ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Aerobic Exercise Intervention for Knee Osteoarthritis

This study is currently recruiting patients.

Sponsored by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

This trial will test if walking or bicycling exercise is effective as a non-surgical treatment option for patients with knee osteoarthritis.

Condition Treatment or Intervention
Osteoarthritis
 Behavior: Walking exercise
 Behavior: Cycling Exercise

MedlinePlus related topics:  Osteoarthritis

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study

Further Study Details: 

Expected Total Enrollment:  306

Study start: October 2002;  Study completion: September 2006

Traditional, conservative medical treatment of osteoarthritis has been directed at improving functional status through reducing joint pain and inflammation and maintaining or restoring joint function. Exercise is an adjunct therapy in the clinical management of patients with osteoarthritis of the knee. However, it is not uniformly accepted. The central hypothesis of this work is that the Surgeon General's exercise guidelines can be successfully implemented as an effective nonsurgical option for treatment of patients with early stages of knee osteoarthritis.

Patients with knee osteoarthritis will be randomized into a control group, a walking exercise group, and a stationary cycling exercise group. The individuals in the exercise groups will be required to exercise three times per week for one year using emerging public health recommendations for aerobic exercise in the adult and aging population. Patient outcome will be assessed using objective gait analysis measurements, knee radiographs to quantify joint space narrowing, magnetic resonance imaging, a general health questionnaire (SF-36), a disease/site specific questionnaire (WOMAC), and a visual-analog pain scale. All subjects will be studied at 0 and 52 weeks.

Eligibility

Ages Eligible for Study:  30 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria

Exclusion Criteria


Location and Contact Information

Kenton R. Kaufman, PhD, PE      507-284-2262    kaufman.kenton@mayo.edu
Christine Hughes      507-266-0985    hughes.christine@mayo.edu

Minnesota
      Mayo Clinic, Rochester,  Minnesota,  55905,  United States; Recruiting

More Information

Study ID Numbers:  NIAMS-081; R01 AR48768
Record last reviewed:  September 2004
Record first received:  November 14, 2002
ClinicalTrials.gov Identifier:  NCT00049816
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act